Occult metastases in lymph nodes predict survival in resectable non-small-cell lung cancer: Report of the ACOSOG Z0040 trial Academic Article uri icon

Overview

MeSH Major

  • Carcinoma, Non-Small-Cell Lung
  • Lung Neoplasms

abstract

  • In early-stage NSCLC, LN OMs detected by IHC identify patients with a worse prognosis. Future clinical trials should test the role of IHC in identifying patients for adjuvant therapy.

publication date

  • November 10, 2011

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC3221530

Digital Object Identifier (DOI)

  • 10.1200/JCO.2011.35.2500

PubMed ID

  • 21990404

Additional Document Info

start page

  • 4313

end page

  • 9

volume

  • 29

number

  • 32